NanoViricides
NNVC
#10077
Rank
โ‚น2.33 B
Marketcap
โ‚น108.44
Share price
-2.42%
Change (1 day)
-15.12%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): -โ‚น52.14

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น54.67. In 2024 the company made an earnings per share (EPS) of -โ‚น62.73 an increase over its 2023 EPS that were of -โ‚น66.32.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น52.14-16.88%
2024-โ‚น62.73-5.41%
2023-โ‚น66.325.71%
2022-โ‚น62.73-13.58%
2021-โ‚น72.59-66.11%
2020-โ‚น214.181.7%
2019-โ‚น210.60-10.98%
2018-โ‚น236.59-22.35%
2017-โ‚น304.69-10.53%
2016-โ‚น340.54375%
2015-โ‚น71.69-85.19%
2014-โ‚น483.9342.11%
2013-โ‚น340.5426.67%
2012-โ‚น268.85-6.25%
2011-โ‚น286.7714.28%
2010-โ‚น250.93100%
2009-โ‚น125.46-0%
2008-โ‚น125.46-33.33%
2007-โ‚น188.19-0%
2006-โ‚น188.194445.07%
2005-โ‚น4.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
-โ‚น4.48-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น189.99-447.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น584.30-1,168.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น266.16-586.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น680.53-1,344.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น322.25-689.50%๐Ÿ‡ฌ๐Ÿ‡ง UK